Annora Pharma Private Limited
Annora Pharma Private Limited appears in FDA public data with 2 recalls, 0 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0626-2026, Class II) was initiated on June 4, 2026.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 4
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0626-2026 | Class II | Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangared | June 4, 2026 |
| D-0391-2026 | Class III | Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LL | February 3, 2026 |